01 18Smart & Biggar
02 6Takeda Canada Inc.
01 32179584
02 32531834
03 62559302
04 62622608
05 62677201
01 18ALOGLIPTIN BENZOATE | PIOGLITAZONE HYDROCHLORIDE
02 6Pioglitazone Hydrochloride
01 18TABLET
02 6Tablet
01 62016-06-20
02 62024-12-15
03 62026-09-13
04 62028-01-30
Patent Expiration Date : 2016-06-20
Date Granted : 2006-12-05
Brand Name : ACTOS
Patent Number : 2531834
Filing Date : 1996-06-20
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-20
Date Granted : 2006-12-05
Patent Expiration Date : 2016-06-20
Date Granted : 2006-12-05
Brand Name : ACTOS
Patent Number : 2531834
Filing Date : 1996-06-20
Strength per Unit : 30 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-20
Date Granted : 2006-12-05
Patent Expiration Date : 2016-06-20
Date Granted : 2006-12-05
Brand Name : ACTOS
Patent Number : 2531834
Filing Date : 1996-06-20
Strength per Unit : 45 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-20
Date Granted : 2006-12-05
Patent Expiration Date : 2016-06-20
Date Granted : 2007-04-24
Brand Name : ACTOS
Patent Number : 2179584
Filing Date : 1996-06-20
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-20
Date Granted : 2007-04-24
Patent Expiration Date : 2016-06-20
Date Granted : 2007-04-24
Brand Name : ACTOS
Patent Number : 2179584
Filing Date : 1996-06-20
Strength per Unit : 30 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-20
Date Granted : 2007-04-24
Patent Expiration Date : 2016-06-20
Date Granted : 2007-04-24
Brand Name : ACTOS
Patent Number : 2179584
Filing Date : 1996-06-20
Strength per Unit : 45 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-20
Date Granted : 2007-04-24
Patent Expiration Date : 2024-12-15
Date Granted : 2012-06-19
ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Patent Number : 2559302
Filing Date : 2004-12-15
Strength per Unit : 25 mg / 15 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-12-15
Date Granted : 2012-06-19
Patent Expiration Date : 2026-09-13
Date Granted : 2014-08-19
ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Patent Number : 2622608
Filing Date : 2006-09-13
Strength per Unit : 25 mg / 15 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-09-13
Date Granted : 2014-08-19
Patent Expiration Date : 2024-12-15
Date Granted : 2012-06-19
ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Patent Number : 2559302
Filing Date : 2004-12-15
Strength per Unit : 25 mg / 30 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-12-15
Date Granted : 2012-06-19
Patent Expiration Date : 2026-09-13
Date Granted : 2014-08-19
ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Patent Number : 2622608
Filing Date : 2006-09-13
Strength per Unit : 25 mg / 30 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-09-13
Date Granted : 2014-08-19
